These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37201859)

  • 21. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiology of invasive fungal disease by filamentous fungi in the period 2005 to 2015, in a university hospital in Santiago, Chile].
    Valenzuela P; Legarraga P; Rabagliati R
    Rev Chilena Infectol; 2019 Dec; 36(6):732-741. PubMed ID: 33660752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive Fungal Infection in Febrile Patients with Hematologic Malignancies Undergoing Chemotherapy in Iran.
    Sheikhbahaei S; Mohammadi A; Sherkat R; Naeini AE; Yaran M; Najafi S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(3):302-307. PubMed ID: 30747087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients.
    Vallejo C; Jarque I; Fortun J; Casado A; Peman J
    J Fungi (Basel); 2023 May; 9(6):. PubMed ID: 37367564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
    Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; Socié G; Porcher R; Ribaud P; Touratier S; Molina JM
    Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients.
    Khatri AM; Natori Y; Anderson A; Jabr R; Shah SA; Natori A; Chandhok NS; Komanduri K; Morris MI; Camargo JF; Raja M
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14162. PubMed ID: 37794708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
    Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
    Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
    Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
    Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.
    Auberger J; Lass-Flörl C; Aigner M; Clausen J; Gastl G; Nachbaur D
    J Antimicrob Chemother; 2012 Sep; 67(9):2268-73. PubMed ID: 22653819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies.
    Strand AM; Alexander BD; Sarpong E; Wong JR; Engemann A; Rizzieri D; Wu Y; Johnson MD
    Mycoses; 2022 Nov; 65(11):1050-1060. PubMed ID: 35816393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
    Bassetti M; Garnacho-Montero J; Calandra T; Kullberg B; Dimopoulos G; Azoulay E; Chakrabarti A; Kett D; Leon C; Ostrosky-Zeichner L; Sanguinetti M; Timsit JF; Richardson MD; Shorr A; Cornely OA
    Intensive Care Med; 2017 Sep; 43(9):1225-1238. PubMed ID: 28255613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Changing Epidemiology of Invasive Fungal Infections.
    Enoch DA; Yang H; Aliyu SH; Micallef C
    Methods Mol Biol; 2017; 1508():17-65. PubMed ID: 27837497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality.
    Vannini M; Emery S; Lieutier-Colas F; Legueult K; Mondain V; Retur N; Gastaud L; Pomares C; Hasseine L
    J Mycol Med; 2022 Mar; 32(1):101210. PubMed ID: 34768155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in management of invasive fungal infections in stem cell transplant.
    Walker J; Edwards WS; Hall NM; Pappas PG
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14175. PubMed ID: 37864814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral and pulmonary aspergillosis, treatment and diagnostic challenges of mixed breakthrough invasive fungal infections: case report study.
    Amanati A; Lotfi M; Masoudi MS; Jafarian H; Ghasemi F; Bozorgi H; Badiee P
    BMC Infect Dis; 2020 Jul; 20(1):535. PubMed ID: 32703183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
    Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
    Biehl LM; Vehreschild JJ; Liss B; Franke B; Markiefka B; Persigehl T; Bücker V; Wisplinghoff H; Scheid C; Cornely OA; Vehreschild MJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2634-41. PubMed ID: 27317443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.
    Rinaldi M; Bartoletti M; Ferrarese A; Franceschini E; Campoli C; Coladonato S; Pascale R; Tedeschi S; Gatti M; Cricca M; Ambretti S; Siniscalchi A; Morelli MC; Cescon M; Cillo U; Di Benedetto F; Burra P; Mussini C; Cristini F; Lewis R; Viale P; Giannella M
    Transpl Infect Dis; 2021 Aug; 23(4):e13608. PubMed ID: 33768656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.